GGrantIndex
← Leaderboards

Richard H Karas

Tufts Medical Center

$14,094,122
Attributed
$14,094,122
Total exposure
8
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200513
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13

Funding mix

By agency

NIH$14,094,122 · 8

By mechanism

R01$6,647,666 · 4
P01$3,695,160 · 2
T32$2,476,129 · 1
P50$1,275,167 · 1

Top collaborators

No co-investigators on record.

Most similar at Tufts Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Estrogen Receptors

Research focus

Estrogen ReceptorsBlood VesselsEstrogensGene ExpressionReportingPathway InteractionsMolecularIn VivoCardiovascular SystemMutantTransfectionGenesPhysiologyMediatingCellsResponseHormonesLigandsSignal TransductionComplexProgramsRegulationBaseImmunocytochemistry

Grant awards (39)

Training Program in Cardiovascular Research$352,527
T32 · FY2013 · HL · contact PI
Training Program in Cardiovascular Research$508,496
T32 · FY2012 · HL · contact PI
Vascular Surgery - Estrogen and the Injury Response$398,475
R01 · FY2012 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$398,475
R01 · FY2012 · HL · contact PI
Training Program in Cardiovascular Research$498,179
T32 · FY2011 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$402,500
R01 · FY2011 · HL · contact PI
Vascular Surgery - Estrogen and the Injury Response$402,500
R01 · FY2011 · HL · contact PI
Training Program in Cardiovascular Research$501,018
T32 · FY2010 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$402,500
R01 · FY2010 · HL · contact PI
Vascular Surgery - Estrogen and the Injury Response$402,500
R01 · FY2010 · HL · contact PI
Training Program in Cardiovascular Research$615,909
T32 · FY2009 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$402,500
R01 · FY2009 · HL · contact PI
Nitric Oxide Signaling Mechanisms in Vascular Cells$390,828
R01 · FY2009 · HL · contact PI
Estrogen and Mechanisms of Cardiomyocyte Protection$347,746
R01 · FY2009 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$15,900
R01 · FY2009 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$402,500
R01 · FY2008 · HL · contact PI
VASCULAR DYSFUNCTION AS AN ETIOLOGY OF HYPERTENSION$399,734
P01 · FY2008 · HL · contact PI
Estrogen and Mechanisms of Cardiomyocyte Protection$347,746
R01 · FY2008 · HL · contact PI
CORE B- MOUSE CORE$340,094
P01 · FY2008 · HL · contact PI
VASCULAR DYSFUNCTION AS AN ETIOLOGY OF HYPERTENSION$379,119
P01 · FY2007 · HL · contact PI
CORE B- MOUSE CORE$350,817
P01 · FY2007 · HL · contact PI
VASCULAR DYSFUNCTION AS AN ETIOLOGY OF HYPERTENSION$390,738
P01 · FY2006 · HL · contact PI
CORE B- MOUSE CORE$362,220
P01 · FY2006 · HL · contact PI
Vascular Estrogen Receptor Signaling Pathways$355,935
R01 · FY2006 · HL · contact PI
VASCULAR DYSFUNCTION AS AN ETIOLOGY OF HYPERTENSION$381,474
P01 · FY2005 · HL
Vascular Estrogen Receptor Signaling Pathways$364,500
R01 · FY2005 · HL
CORE B- MOUSE CORE$339,914
P01 · FY2005 · HL
VASCULAR DYSFUNCTION AS AN ETIOLOGY OF HYPERTENSION$419,800
P01 · FY2004 · HL
Vascular Estrogen Receptor Signaling Pathways$364,500
R01 · FY2004 · HL
CORE B- MOUSE CORE$331,250
P01 · FY2004 · HL
CARDIAC ESTROGEN RECEPTORS AND MI-- MOUSE MODELS$267,993
P50 · FY2004 · HL
Vascular Estrogen Receptor Signaling Pathways$364,500
R01 · FY2003 · HL
CARDIAC ESTROGEN RECEPTORS AND MI-- MOUSE MODELS$260,975
P50 · FY2003 · HL
VASCULAR ESTROGEN RECEPTOR SIGNALING PATHWAYS$303,441
R01 · FY2002 · HL
CARDIAC ESTROGEN RECEPTORS AND MI-- MOUSE MODELS$254,699
P50 · FY2002 · HL
VASCULAR ESTROGEN RECEPTOR SIGNALING PATHWAYS$294,600
R01 · FY2001 · HL
CARDIAC ESTROGEN RECEPTORS AND MI-- MOUSE MODELS$248,983
P50 · FY2001 · HL
VASCULAR ESTROGEN RECEPTOR SIGNALING PATHWAYS$286,020
R01 · FY2000 · HL
CARDIAC ESTROGEN RECEPTORS AND MI-- MOUSE MODELS$242,517
P50 · FY2000 · HL